The FDA has cleared Brainstorm to initiate a Phase 3b clinical trial testing NurOwn (debamestrocel) in people with moderate ...

ATH-1105, an experimental oral therapy for ALS, was found to be safe and well tolerated in healthy adult volunteers in a ...

What does coping mean in life? Columnist Kristin Neva mulls it over after she and her husband with ALS take a mental health survey.

Patients given Neuronata-R who progressed more slowly saw significant gains in CAFS, slower declines in ALSFRS-R scores, and ...

MaaT033, an experimental oral therapy that uses bacteria to restore balance in the gut, may slow ALS progression, a study ...

Massachusetts General Hospital's 2025 MGH ALS Young Investigator Awards went to three scholars doing ALS research.

Patients with less neuronal damage, determined by low spinal fluid pNFH, had a 48% reduction in the risk of death by adding IL-2 to riluzole.

ALS Awareness Month amplifies difficult emotions for columnist. It's one of the reasons why sharing is important.

The ALS therapy ATLX-1282 was developed with AIchemab's platform, which uses AI to identify therapeutic targets for difficult ...

Clene will soon meet with the Food and Drug Administration to discuss analyses that could support an application for ...